Trachea mucoepidermoid carcinoma

Summary

Trachea mucoepidermoid carcinoma (MONDO:0000534) is a cancer. A subtype of mucoepidermoid carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	trachea mucoepidermoid carcinoma
Mondo ID	MONDO:0000534
DOID	DOID:0050919
SNOMED CT	707379000
UMLS	C3873401
MedGen	835970
GARD	0022793
Anatomy (UBERON)	UBERON:0003126
Is cancer (heuristic)	yes

Also known as: trachea mucoepidermoid carcinoma

Disease family

This is a subtype of mucoepidermoid carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › mucinous adenocarcinoma › mucoepidermoid carcinoma › trachea mucoepidermoid carcinoma

Related subtypes (11): thymic mucoepidermoid carcinoma, mucoepidermoid breast carcinoma, extrahepatic bile duct mucoepidermoid carcinoma, cutaneous mucoepidermoid carcinoma, lacrimal gland mucoepidermoid carcinoma, mucoepidermoid esophageal carcinoma, laryngeal mucoepidermoid carcinoma, pulmonary mucoepidermoid carcinoma, thyroid gland mucoepidermoid carcinoma, paranasal sinus mucoepidermoid carcinoma, oral cavity mucoepidermoid carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.